Search

Your search keyword '"Cooper MR"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Cooper MR" Remove constraint Author: "Cooper MR" Journal journal of clinical oncology official journal of the american society of clinical oncology Remove constraint Journal: journal of clinical oncology official journal of the american society of clinical oncology
31 results on '"Cooper MR"'

Search Results

2. Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

3. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

4. Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.

5. Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.

6. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

7. Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741.

8. Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study.

9. Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group B.

10. Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.

11. Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin.

12. Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.

14. Trimetrexate in malignant mesothelioma: A Cancer and Leukemia Group B Phase II study.

15. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

16. AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B study.

17. A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study.

18. Mood and clinical status in patients with multiple myeloma.

19. High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.

20. Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.

21. Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB Study.

22. A phase II study of recombinant alpha interferon in patients with recurrent or metastatic breast cancer.

23. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.

24. Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.

25. Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience.

26. Improvement of long-term survival in extensive small-cell lung cancer.

27. Tamoxifen rechallenge: response to tamoxifen following relapse after adjuvant chemohormonal therapy for breast cancer.

28. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.

29. The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.

30. Single agent vincristine by infusion in refractory multiple myeloma.

31. Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study.

Catalog

Books, media, physical & digital resources